Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue EstimatesZacks Investment Research • 02/12/26
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026GlobeNewsWire • 01/27/26
Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key FactsZacks Investment Research • 01/24/26
PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC ResearchZacks Investment Research • 01/15/26
Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic DiseasesGlobeNewsWire • 01/12/26
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)GlobeNewsWire • 01/12/26
PacBio Stock Dips Post Latest Launch to Expand Multiomics CapabilitiesZacks Investment Research • 01/09/26
PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT CellGlobeNewsWire • 01/08/26
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/YZacks Investment Research • 11/06/25
Pacific Biosciences of California, Inc. (PACB) Q3 2025 Earnings Call TranscriptSeeking Alpha • 11/06/25
Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/06/25
Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/05/25
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi GenomesGlobeNewsWire • 11/05/25
Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 11/04/25
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in ChinaGlobeNewsWire • 11/04/25